drugset / Trial / NCT02277782

Intrathecal Hydromorphone for Labor Analgesia

NCT02277782

Terminated 21 enrolled Brigham and Women's Hospital
RandomizedSingle-groupQuadruple-blindPrevention

Summary

The objective of this study is to evaluate the effect of intrathecal hydromorphone on the duration of labor analgesia and the incidence of epidural-associated temperature increase in laboring parturients. We hypothesize that intrathecal administration of longer-acting hydromorphone will: 1. Prolong the duration and improve the quality of analgesia in labor, and 2. Decrease the incidence of epidural-associated temperature increase in labor.

Timeline

Start
2015-09-01
Primary completion
2019-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified 50 ug Intrathecal
Background Bupivacaine Other / unclassified 1.7 mg
Background Fentanyl Other / unclassified 17 ug

Indications